Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/43092
Citations | ||
Scopus | Web of ScienceĀ® | Altmetric |
---|---|---|
?
|
?
|
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mackenzie, F. | - |
dc.contributor.author | Jordens, C. | - |
dc.contributor.author | Ankeny, R. | - |
dc.contributor.author | McPhee, J. | - |
dc.contributor.author | Kerridge, I. | - |
dc.date.issued | 2007 | - |
dc.identifier.citation | Internal Medicine Journal, 2007; 37(4):224-228 | - |
dc.identifier.issn | 1444-0903 | - |
dc.identifier.issn | 1445-5994 | - |
dc.identifier.uri | http://hdl.handle.net/2440/43092 | - |
dc.description | The definitive version is available at www.blackwell-synergy.com | - |
dc.description.abstract | Direct-to-consumer advertising of prescription medicines (DTCA-PM) is currently banned in Australia. DTCA-PM is thought to increase health-care costs by increasing demand for drugs that are both expensive and potentially harmful. However, DTCA-PM is occurring in Australia despite the current prohibition. We argue that successful regulation of the practice has been undermined as a result of changes brought about by the ongoing communications revolution, the increasing centrality of patient choice in medical decision-making and the impossibility of drawing and maintaining a sharp distinction between information and advertising. The prohibition is further threatened by recent international trade agreements. These factors make DTCA-PM inevitable and legislative and professional bodies need to acknowledge this to create a more effective health-care policy. | - |
dc.description.statementofresponsibility | F. J. Mackenzie, C. F. C. Jordens, R. A. Ankeny, J. McPhee and I. H. Kerridge | - |
dc.language.iso | en | - |
dc.publisher | Blackwell Publishing Asia | - |
dc.source.uri | http://dx.doi.org/10.1111/j.1445-5994.2006.01298.x | - |
dc.subject | Humans | - |
dc.subject | Information Dissemination | - |
dc.subject | Decision Making | - |
dc.subject | Health Policy | - |
dc.subject | Advertising | - |
dc.subject | Drug Industry | - |
dc.subject | Patient Participation | - |
dc.subject | Australia | - |
dc.title | Direct-to-consumer advertising under the radar: the need for realistic drugs policy in Australia | - |
dc.type | Journal article | - |
dc.identifier.doi | 10.1111/j.1445-5994.2006.01298.x | - |
pubs.publication-status | Published | - |
dc.identifier.orcid | Ankeny, R. [0000-0002-1547-6031] | - |
Appears in Collections: | Aurora harvest 6 History publications |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.